Sec Form 4/A Filing - LONDONER KENNETH L @ BioSig Technologies, Inc. - 2015-07-30

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4/A
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
LONDONER KENNETH L
2. Issuer Name and Ticker or Trading Symbol
BioSig Technologies, Inc. [ BSGM]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
C/O BIOSIG TECHNOLOGIES, INC., 8441 WAYZATA BLVD., SUITE 240
3. Date of Earliest Transaction (MM/DD/YY)
07/30/2015
(Street)
MINNEAPOLIS, MN55426
4. If Amendment, Date Original Filed (MM/DD/YY)
08/07/2015
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, $0.001 par value per share 07/30/2015 P 100 ( 1 ) A $ 1.87 519,650 D
Common Stock, $0.001 par value per share 07/31/2015( 2 ) P 100 ( 3 ) A $ 1.82 519,750 D
Common Stock, $0.001 par value per share 08/03/2015 P 300 A $ 1.74 ( 4 ) ( 5 ) 520,050 D
Common Stock, $0.001 par value per share 08/06/2015 P 1,200 ( 6 ) A $ 1.79 ( 7 ) ( 8 ) 521,250 ( 9 ) D
Common Stock, $0.001 par value per share 3,334,974 I By Endicott Management Partners, LLC ( 10 )
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
LONDONER KENNETH L
C/O BIOSIG TECHNOLOGIES, INC.
8441 WAYZATA BLVD., SUITE 240
MINNEAPOLIS, MN55426
X X
Signatures
/s/ Kenneth L. Londoner 03/31/2017
Signature of Reporting Person Date
Explanation of Responses:
( 1 )The number of shares reported for this line item was erroneously reported to be 1,000 shares on the Reporting Person's original Form 4.
( 2 )The date of the transaction referenced in this line item was erroneously reported to be "07/30/2015" on the Reporting Person's original Form 4.
( 3 )The number of shares reported for this line item was erroneously reported to be 1,000 shares on the Reporting Person's original Form 4.
( 4 )The price indicated is the weighted average of multiple same-way trades ranging in price from $1.72 to $1.75. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
( 5 )The price figure provided for this line item was erroneously reported to be "$1.75" in the Reporting Person's original Form 4. Additionally, the figure did not purport to provide a weighted average.
( 6 )The number of shares purchased in the transactions referenced in this aggregated line item was erroneously reported, in separate line items, to be 2,100 on the Reporting Person's original Form 4.
( 7 )The price indicated is the weighted average of multiple same-way trades ranging in price from $1.74 to $1.85. Upon request by the SEC staff, the issuer, or any security holder of the issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
( 8 )The price figures provided for the transactions referenced in this line item were reported in the Reporting Person's original Form 4 simply as "$1.79" and"$1.75", respectively. The figure in this Amendment provides a weighted average.
( 9 )The running total of securities beneficially owned set forth in Table I, Column 5 of the Reporting Person's original Form 4 has been amended to reflect the foregoing amendments.
( 10 )The Reporting Person is deemed the beneficial owner of securities held by Endicott Management Partners, LLC.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.